We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biovail Takes Aim At FDA Over Generic Wellbutrin

Law360 (August 24, 2006, 12:00 AM EDT) -- Biovail Corp. has filed suit against the U.S. Food and Drug Administration, underscoring that the company does not intend to surrender its lucrative branded drug Wellbutrin XL to generic companies without...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.